Background: The aim of this study was to assess the interdependence of extracorporeal blood flow (Qec) and gas flow (GF) in predicting CO removal and reduction of minute mechanical ventilation under extracorporeal respiratory support.
Methods: All patients who benefited from V-V ECMO and high-flow ECCO R in our intensive care unit over a period of 18 months were included. CO removal was calculated from inlet/outlet blood port gases during the first 7 days of oxygenator use. The relationship between the Qec × GF product (named decarboxylation index and expressed in L /min ) and CO removal or expired minute mechanical ventilation reduction ( MV ratio) was studied using linear regression models.
Results: Eighteen patients were analyzed, corresponding to 24 oxygenators and 261 datasets. CO removal was 393 ml/min (IQR, 310-526) for 1.8 m oxygenators and 179 ml/min (IQR, 165-235) for 1.3 m oxygenators. The decarboxylation index was associated linearly with CO removal (R = 0.62 and R = 0.77 for the two oxygenators, respectively) and MV ratio (R = 0.72 and R = 0.62, respectively). The 20L /min value (considering Qec = 2 L/min and GF = 10 L/min) was associated with an MV ratio between 61% and 29% for 1.8 m oxygenators, and between 62% and 38% for 1.3 m oxygenators.
Conclusion: The decarboxylation index is a simple parameter to predict CO removal and MV ratio under extracorporeal respiratory support.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/aor.14471 | DOI Listing |
J Cardiothorac Surg
January 2025
Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Background: Carinal resection and reconstruction are complex surgical procedures often necessitated by tumors or other pathologies involving the tracheobronchial junction. Traditional approaches to these surgeries are highly invasive. The advent of uniportal video-assisted thoracoscopic surgery (VATS) along with the integration of extracorporeal membrane oxygenation (ECMO) offer potential advantages in reducing surgical trauma and improving outcomes.
View Article and Find Full Text PDFRev Cardiovasc Med
December 2024
Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China.
Cardiovasc Drugs Ther
December 2024
AP-HP, Hôpitaux Universitaires Henri-Mondor, Service de Médecine Intensive Réanimation, 94010, Créteil, France.
Purpose: Hypoxemia is a risk factor for mortality and long-term neuropsychological impairment during severe acute respiratory distress syndrome (ARDS). Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is a potential treatment for such cases but may not suffice. We aimed to evaluate the effects of pharmacological interventions for cardiac output (CO) control using ivabradine or beta-blockers for refractory hypoxemia during VV-ECMO.
View Article and Find Full Text PDFSci Rep
December 2024
Department of Critical Care Medicine, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, 324000, Zhejiang, China.
Fluid administration is widely used to treat hypotension in patients undergoing veno-venous extracorporeal membrane oxygenation (VV-ECMO). However, excessive fluid administration may lead to fluid overload can aggravate acute respiratory distress syndrome (ARDS) and increase patient mortality, predicting fluid responsiveness is of great significance for VV-ECMO patients. This prospective single-center study was conducted in a medical intensive care unit (ICU) and finally included 51 VV-ECMO patients with ARDS in the prone position (PP).
View Article and Find Full Text PDFResuscitation
December 2024
Department of Cardiology, Paracelsus Medical University, Prof.-Ernst-Nathan-Str. 1, 90419 Nuremberg, Germany.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!